DSDavid Spain

David Spain

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


David Spain has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Safety and effectiveness of high‐dose midazolam for severe behavioural disturbance in an emergency department with suspected psychostimulant‐affected patients

    by David Spain, Julia Crilly, Ian Whyte, Linda Jenner, Vaughan Carr, Amanda Baker

    Objectives:  To trial high‐dose midazolam sedation protocol for uncooperative patients with suspected psychostimulant‐induced behavioural disorders. End‐points were effectiveness and safety.Methods:  A prospective pilot study was undertaken with a convenience sample of adult, uncooperative patients with suspected psychostimulant‐induced severe behavioural disorders. The protocol was midazolam in 10 mg increments, i.m. or i.v., at 10 min intervals, up to four doses and titrated to an end‐point of rousable drowsiness.Results:  Sixty‐two patients were enrolled. Two‐thirds of the patients required only one dose of midazolam; 88% of the sample were sedated with two doses. Six and a half per cent of patients were not sedated after four doses. A Glasgow Coma Score of eight or less was prolonged in eight patients. Airway problems requiring an adjunct were present in four patients. Recent psychostimulant use was present in only 55% after full assessment.Conclusions:  High‐dose midazolam protocols cannot be supported as universally safe. High‐dose protocols for severe behavioural disturbance are not more effective, with failures occurring even after repeated dosing.